Advances of linac-based boron neutron capture therapy in korea

HIGHLIGHTS

• who: Young-soon Bae from the Currently, the most widely used boron delivery agent for BNCT clinical trials is boronophenylalanine (BPA)BPA is a compound of amino acid phenylalanine bound to a single atom of boron. The boron content of BPA is about, % by molecular weight. Next, we consider the epithermal neutron source for BNCT. Originally, the only sources for neutron beams with sufficient intensity were research reactors. Clinical trials have been conducted around the world using research reactors for neutron sources since the, s: MITR at MIT, BMRR at BNL both in the USA have published . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.